What is the elimination half-life of isotretinoin (Accutane)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 1, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Half-Life of Isotretinoin (Accutane)

The elimination half-life of isotretinoin is approximately 21 hours in adults and 15.7 hours in pediatric patients (ages 12-15 years), based on FDA-approved prescribing information. 1

Pharmacokinetic Details

The FDA drug label provides the most authoritative data on isotretinoin elimination:

  • Adults: Mean elimination half-life of 21 ± 8.2 hours after a single 80 mg oral dose under fed conditions 1
  • Pediatric patients (12-15 years): Mean elimination half-life of 15.7 ± 5.1 hours 1
  • Major metabolite (4-oxo-isotretinoin): Half-life of 24 ± 5.3 hours in adults and 23.1 ± 5.7 hours in pediatric patients 1

Important Clinical Context

The half-life remains unchanged whether isotretinoin is taken with or without food, though food more than doubles the bioavailability (Cmax and AUC) 1. This is why isotretinoin must always be taken with meals.

Following oral administration of radiolabeled isotretinoin, the 14C-activity in blood declined with a half-life of 90 hours, reflecting the longer persistence of metabolites and conjugates 1. However, the parent drug itself clears much faster at approximately 21 hours.

Variability in Research Literature

Earlier research studies reported somewhat variable half-life estimates:

  • One study in women of childbearing age found a mean half-life of 29 ± 40 hours, likely due to longer sampling periods (up to 28 days) 2
  • Classic studies from the 1980s reported half-lives ranging from 10-20 hours 3, 4, 5, 6
  • A 1985 study found approximately 14.7 hours across different dose levels 6

The FDA label data should be considered definitive, as it represents the most rigorous pharmacokinetic analysis with standardized methodology 1.

Clinical Implications

The relatively short half-life of isotretinoin means:

  • Steady-state concentrations are achieved within approximately 5-7 days of daily dosing 5
  • The drug follows linear pharmacokinetics without significant accumulation beyond what's predicted by the half-life 5
  • Contraception requirements extend far beyond drug elimination: Women must use contraception for 1 month after stopping isotretinoin (not 3 years—that's for acitretin, a different retinoid) 7

Critical Distinction from Acitretin

Do not confuse isotretinoin with acitretin (used for psoriasis). Acitretin has a half-life of 49 hours but can convert to etretinate (half-life 168 days), requiring 3 years of contraception after discontinuation 8. Isotretinoin does not undergo this conversion and clears much faster.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.